Sign in

CIK 0001367644

  • Accelerated filer

Emergent BioSolutions Inc.

Sign in to watch
Ticker
EBS
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
141902018
Phone
+1 240-631-3200
Business address
300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
  1. 4 Open-market buy EVP, Chief Financial Officer bought 3,000 shares at $37.46 ($112,380)
  2. 4 Open-market sale Director sold 3,139 shares at $56.48 ($177,291)
  3. 4 Grant or award Director acquired 5,027 shares (grant or award)
  4. 4 Grant or award Director acquired 5,027 shares (grant or award)
  5. 4 Grant or award Director acquired 5,027 shares (grant or award)
  6. 4 Grant or award Director acquired 5,027 shares (grant or award)
  7. 4 Grant or award Director acquired 5,027 shares (grant or award)
  8. 4 Grant or award Director acquired 5,027 shares (grant or award)
  9. 4 Grant or award Director acquired 5,027 shares (grant or award)
  10. 4 Shares withheld for taxes EVP, Chief Medical Officer gave up 305 shares (to pay taxes)
  11. 4 Shares withheld for taxes EVP, Chief Financial Officer gave up 1,054 shares (to pay taxes)
  12. 4 Shares withheld for taxes President and CEO gave up 94 shares (to pay taxes)
  13. 4 Shares withheld for taxes Director gave up 3,118 shares (to pay taxes)
  14. 4 Shares withheld for taxes EVP, Manufacturing & Tech Ops gave up 159 shares (to pay taxes)
  15. 4 Open-market sale Director sold 8,168 shares at $92.37 ($754,478)
  16. 4 Open-market sale EVP, Business Operations sold 37,279 shares at an average $99.30 ($3,701,647)
  17. 4 Derivatives Options or other derivatives
  18. 4 Shares withheld for taxes EVP, Business Operations gave up 2,318 shares (to pay taxes)
  19. 4 Shares withheld for taxes President and CEO gave up 5,001 shares (to pay taxes)
  20. 4 Grant or award EVP, Manufacturing & Tech Ops acquired 6,418 shares (grant or award)

Page 12 of 49 · 970 filings